The next time you’re preparing to plan a meeting, you’ll see a dedicated Help me schedule button in the toolbar. If you tap ...
Imdelltra combined with chemotherapy and PD-L1 therapy showed a 71% objective response rate and 82% disease control rate in ...
US President Donald Trump reportedly pressed Ukrainian President Volodymyr Zelensky to accept Russian terms for ending the ...
AstraZeneca and Daiichi Sankyo's Datroway (datopotamab deruxtecan) came out of the blocks strongly at the ESMO congress with ...
Seven universities rejected a proposal linking federal funds to academic freedom rules, citing threats to institutional ...
Everyone knows that smartphone security updates are important, but did you know that Samsung pledged to extend the update ...
Julia Ioffe’s much-anticipated memoir and history of Russia offers an original take on America’s long-time adversary ...
Trodelvy plus Keytruda may maintain QOL and delay physical decline in PD-L1-positive mTNBC patients. The combination therapy showed improved progression-free survival and reduced symptom burden ...
Palazestrant in combination with ribociclib demonstrated encouraging activity across all dose cohorts and subgroups Median PFS was 15.5 months in the 120 mg palazestrant cohort across all patientsIn ...
During a live event, Nizar M. Tannir, MD and participants discussed their takeaways from trial data on recurrent RCC ...
Following a Joe Rogan, Mel Gibson podcast, Florida wants to study whether ivermectin could work against cancer. There is not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback